Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy CTi Biopharma stock

Learn how to easily invest in CTi Biopharma stock.

CTi Biopharma Corp is a biotechnology business based in the US. CTi Biopharma shares (CTIC) are listed on the NASDAQ and all prices are listed in US Dollars. CTi Biopharma employs 121 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in CTi Biopharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CTIC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

CTi Biopharma stock price (NASDAQ: CTIC)

Use our graph to track the performance of CTIC stocks over time.

CTi Biopharma shares at a glance

Information last updated 2022-07-03.
Latest market close$6.08
52-week range$1.43 - $6.52
50-day moving average $5.26
200-day moving average $3.49
Wall St. target price$9.58
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.23

Buy CTi Biopharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CTi Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CTi Biopharma price performance over time

Historical closes compared with the close of $6.08 from 2022-07-01

1 week (2022-06-28) 9.75%
1 month (2022-06-03) 5.74%
3 months (2022-04-05) 28.00%
6 months (2022-01-05) 162.07%
1 year (2021-07-02) 133.85%
2 years (2020-07-02) 415.25%
3 years (2019-07-05) 646.56%
5 years (2017-07-05) 80.42%

CTi Biopharma financials

Revenue TTM $2.3 million
Gross profit TTM $3.3 million
Return on assets TTM -81.33%
Return on equity TTM -447.11%
Profit margin 0%
Book value $0.04
Market capitalisation $662.5 million

TTM: trailing 12 months

CTi Biopharma share dividends

We're not expecting CTi Biopharma to pay a dividend over the next 12 months.

Have CTi Biopharma's shares ever split?

CTi Biopharma's shares were split on a 1:10 basis on 2 January 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CTi Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for CTi Biopharma shares which in turn could have impacted CTi Biopharma's share price.

CTi Biopharma share price volatility

Over the last 12 months, CTi Biopharma's shares have ranged in value from as little as $1.43 up to $6.52. A popular way to gauge a stock's volatility is its "beta".

CTIC.US volatility(beta: 0.98)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CTi Biopharma's is 0.9837. This would suggest that CTi Biopharma's shares are less volatile than average (for this exchange).

CTi Biopharma overview

CTI BioPharma Corp. , a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. ; S*BIO Pte Ltd. ; and Baxalta. The company was formerly known as Cell Therapeutics, Inc.

Frequently asked questions

What percentage of CTi Biopharma is owned by insiders or institutions?
Currently 0.209% of CTi Biopharma shares are held by insiders and 62.611% by institutions.
How many people work for CTi Biopharma?
Latest data suggests 121 work at CTi Biopharma.
When does the fiscal year end for CTi Biopharma?
CTi Biopharma's fiscal year ends in December.
Where is CTi Biopharma based?
CTi Biopharma's address is: 3101 Western Avenue, Seattle, WA, United States, 98121
What is CTi Biopharma's ISIN number?
CTi Biopharma's international securities identification number is: US12648L6011
What is CTi Biopharma's CUSIP number?
CTi Biopharma's Committee on Uniform Securities Identification Procedures number is: 12648L106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site